CANC logo

CANC Overview

Profile

Name:

Tema Oncology ETF

Assets under management:

$48 M

Expense ratio:

0.75%

Inception date:

August 14, 2023

Website:

-

Last ex-dividend date:

December 11, 2024

Next ex-dividend date:

N/A

Description:

CANC ETF is an exchange-traded fund that focuses on companies involved in cancer research and treatment. It aims to provide investors with exposure to the growing healthcare sector, particularly in oncology, by investing in stocks of firms developing innovative cancer therapies and technologies.

Top holdings

Name
Weight
LLY logo
Eli Lilly and Company(LLY)
5.44 %
ROCHE HOLDING AG(RHHBY)
5.25 %
RVMD logo
Revolution Medicines(RVMD)
5.11 %
ASTRAZENECA PLC(AZN.L)
4.49 %
BMY logo
Bristol-Myers Squibb(BMY)
4.48 %
NOVARTIS AG(NOVN.SW)
4.12 %
EXEL logo
Exelixis(EXEL)
4.10 %
GMAB logo
Genmab A/S(GMAB)
3.69 %
BBIO logo
BridgeBio Pharma(BBIO)
3.61 %
NUVL logo
Nuvalent(NUVL)
3.57 %
CHUGAI PHARMACEUTICAL CO., LTD.(4519.T)
3.15 %
MRUS logo
Merus NV(MRUS)
3.12 %
ACLX logo
Arcellx(ACLX)
2.99 %
AMGN logo
Amgen(AMGN)
2.98 %
MRK logo
Merck & Co(MRK)
2.97 %
BeiGene(ONC)
2.88 %
DAIICHI SANKYO CO., LTD.(4568.T)
2.83 %
LEGN logo
Legend Biotech(LEGN)
2.73 %
BPMC logo
Blueprint Medicines(BPMC)
2.72 %
SMMT logo
Summit Therapeutics(SMMT)
2.59 %
ABBV logo
AbbVie(ABBV)
2.11 %
JANX logo
Janux Therapeutics(JANX)
2.09 %
ZLAB logo
Zai Lab Limited(ZLAB)
1.92 %
GILD logo
Gilead Sciences(GILD)
1.91 %
ARGX logo
argenx SE(ARGX)
1.80 %
IDYA logo
IDEAYA Biosciences(IDYA)
1.30 %
REGN logo
Regeneron Pharmaceuticals(REGN)
1.15 %
DAWN logo
Day One Biopharmaceuticals(DAWN)
1.03 %
MREO logo
Mereo BioPharma(MREO)
0.98 %
ARVN logo
Arvinas(ARVN)
0.98 %

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$24.91
CANC price is $24.91

Price All-time High

$29.96
CANC price is currently -16.87% below its historical high of $29.96

Price Today Change

-1.01%
CANC price is down -1.01% today

Price YTD Change

+2.46%
CANC price is up +2.46% since January 1st

Price 1-Year Change

-10.35%
CANC price is down -10.35% year-on-year

Price 3-Year Change

-
CANC price 3-year change is unknown

Technical Analysis

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.85
CANC beta is 0.85

200-day SMA

$27.21
CANC price is currently -8.46% below its 200-day simple moving average

14-day RSI

44.80
CANC 14-day relative strength index is 44.80

30-day Relative Volume

0.67
CANC 30-day relative volume is 0.67

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend per share

Last Paid Dividend

$0.73
CANC last dividend was $0.73 per share, with an ex-dividend date of December 11, 2024

TTM Dividend Per Share

$0.73
CANC TTM dividend per share is $0.73

TTM Dividend Per Share 1-Year Change

+388.46%
CANC TTM dividend per share is up +388.46% year-on-year

TTM Dividend Per Share 3-Year Change

-
CANC TTM dividend per share 3-year change is unknown

Dividend yield

TTM Dividend Yield

2.92%
CANC TTM dividend yield is 2.92%

TTM Dividend Yield 1-Year Change

+440.74%
CANC TTM dividend yield is up +440.74% year-on-year

Top holdings

Name
Weight
LLY logo
Eli Lilly and Company(LLY)
5.44 %
ROCHE HOLDING AG(RHHBY)
5.25 %
RVMD logo
Revolution Medicines(RVMD)
5.11 %
ASTRAZENECA PLC(AZN.L)
4.49 %
BMY logo
Bristol-Myers Squibb(BMY)
4.48 %
NOVARTIS AG(NOVN.SW)
4.12 %
EXEL logo
Exelixis(EXEL)
4.10 %
GMAB logo
Genmab A/S(GMAB)
3.69 %
BBIO logo
BridgeBio Pharma(BBIO)
3.61 %
NUVL logo
Nuvalent(NUVL)
3.57 %
CHUGAI PHARMACEUTICAL CO., LTD.(4519.T)
3.15 %
MRUS logo
Merus NV(MRUS)
3.12 %
ACLX logo
Arcellx(ACLX)
2.99 %
AMGN logo
Amgen(AMGN)
2.98 %
MRK logo
Merck & Co(MRK)
2.97 %
BeiGene(ONC)
2.88 %
DAIICHI SANKYO CO., LTD.(4568.T)
2.83 %
LEGN logo
Legend Biotech(LEGN)
2.73 %
BPMC logo
Blueprint Medicines(BPMC)
2.72 %
SMMT logo
Summit Therapeutics(SMMT)
2.59 %
ABBV logo
AbbVie(ABBV)
2.11 %
JANX logo
Janux Therapeutics(JANX)
2.09 %
ZLAB logo
Zai Lab Limited(ZLAB)
1.92 %
GILD logo
Gilead Sciences(GILD)
1.91 %
ARGX logo
argenx SE(ARGX)
1.80 %
IDYA logo
IDEAYA Biosciences(IDYA)
1.30 %
REGN logo
Regeneron Pharmaceuticals(REGN)
1.15 %
DAWN logo
Day One Biopharmaceuticals(DAWN)
1.03 %
MREO logo
Mereo BioPharma(MREO)
0.98 %
ARVN logo
Arvinas(ARVN)
0.98 %

Analyst ratings

FAQ

  • What is CANC?
  • Does CANC pay dividends?
  • What stocks are in CANC?
  • What is the current assets under management for CANC?
  • What is CANC average volume?
  • What is CANC expense ratio?
  • What is CANC inception date?

What is CANC?

CANC ETF is an exchange-traded fund that focuses on companies involved in cancer research and treatment. It aims to provide investors with exposure to the growing healthcare sector, particularly in oncology, by investing in stocks of firms developing innovative cancer therapies and technologies.

Does CANC pay dividends?

Yes, the Tema Oncology ETF does pays dividends, with the most recent payment being $0.73 per share. The last ex-dividend date was on December 11, 2024, and the next ex-dividend date has not been announced yet

What stocks are in CANC?

As of today, Tema Oncology ETF inlcudes 52 holdings, with 46 of them being companies from 8 different countries and 1 sectors. The most weighted holdings are Eli Lilly and Company (5.44%), ROCHE HOLDING AG (5.25%) and Revolution Medicines (5.11%)

What is the current assets under management for CANC?

Assets under management of Tema Oncology ETF is $48 M

What is CANC average volume?

Average volume of Tema Oncology ETF is $20 K

What is CANC expense ratio?

Expense ratio of Tema Oncology ETF is 0.75%

What is CANC inception date?

Inception date of Tema Oncology ETF is August 14, 2023